Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental therapies for psoriasis.

Khusru Asadullah1, Hans-Dieter Volk, Markus Friedrich

  • 1Corporate Research Business Area Dermatology, Schering AG, D-13342 Berlin, Germany. khusru.asadullah@schering.de

Archivum Immunologiae Et Therapiae Experimentalis
|January 28, 2003
PubMed
Summary

New therapies for psoriasis are in development, targeting immune pathways. These experimental treatments offer hope for better management of this immune disease and potentially other T cell-mediated disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation.

Molecular therapy. Advances·2026
Same author

Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation.

Molecular therapy. Nucleic acids·2026
Same author

The Impact of Evaluation Strategy on Sepsis Prediction Model Performance Metrics in Intensive Care Data: Retrospective Cohort Study.

Journal of medical Internet research·2026
Same author

Prediction and risk evaluation of delirium after surgery in older patients: development and internal validation of an algorithm from the prospective BioCog cohort study.

British journal of anaesthesia·2026
Same author

mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cells.

Molecular therapy. Nucleic acids·2026
Same author

HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model.

Nature communications·2025

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Psoriasis is a common immune disease with significant unmet medical needs.
  • Current understanding of psoriasis pathophysiology is evolving.
  • Novel systemic immunomodulatory therapies are emerging.

Purpose of the Study:

  • To review the rationale behind novel experimental therapies for psoriasis.
  • To present initial clinical data on these emerging treatments.
  • To explore the potential impact on other immune disorders.

Main Methods:

  • Review of clinical development approaches.
  • Analysis of therapies targeting antigen presentation, costimulation, T cell activation, leukocyte adhesion, proinflammatory mediators, and cytokine balance.

Related Experiment Videos

  • Examination of preliminary clinical trial data.

    • Main Results:

    • Several novel immunomodulatory therapies are in clinical development for psoriasis.
    • Preliminary data suggest these approaches contribute to understanding the disease.
    • These therapies target key immune pathways involved in psoriasis pathogenesis.

    Conclusions:

    • Emerging therapies show promise for improved psoriasis treatment.
    • Further clinical development is expected to yield new therapeutic options.
    • Psoriasis research may inform treatments for other T cell-mediated disorders.